PTCT
PTC Therapeutics Inc
NASDAQ: PTCT · HEALTHCARE · BIOTECHNOLOGY
$64.55
-8.13% today
Updated 2026-04-29
Market cap
$5.83B
P/E ratio
8.19
P/S ratio
3.37x
EPS (TTM)
$8.58
Dividend yield
—
52W range
$36 – $88
Volume
1.2M
PTC Therapeutics Inc (PTCT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$64.55
12-Month target
$64.52
2030 Target
—
Intrinsic (DCF)
$89.55
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.5B | $0.7B | $0.9B | $0.8B | $1.7B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 8.19x (capped 25x) · Margin: 39.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.